Assessment of Dual Antiplatelet Therapy Versus Rivaroxaban In Atrial Fibrillation Patients Treated With Left Atrial Appendage Closure: The Randomized ADRIFT Study
Phase of Trial: Phase II/III
Latest Information Update: 22 Sep 2017
At a glance
- Drugs Rivaroxaban (Primary) ; Aspirin; Clopidogrel
- Indications Atrial fibrillation
- Focus Therapeutic Use
- Acronyms ADRIFT
- 31 Aug 2018 Biomarkers information updated
- 19 Sep 2017 Planned End Date changed from 20 Dec 2018 to 23 Dec 2018.
- 19 Sep 2017 Planned primary completion date changed from 20 Sep 2018 to 23 Sep 2018.